LIGAND PHARMACEUTICALS INC — Director's Dealing 2021

Jul 15, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LIGAND PHARMACEUTICALS INC (LGND)
CIK: 0000886163
Period of Report: 2021-07-12

Reporting Person: Cochran Jennifer R. (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-07-12	Common Stock	A	1161	$0.0	Acquired	1161	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-07-12	Non-Qualified Stock Option (right to buy)	$126.36	A	4508	Acquired	2031-07-12	Common Stock (4508)	Direct

Footnotes

F1: The option becomes exercisable in 3 successive annual installments upon completion of each calendar year of service beginning on the grant date.